Ovid Therapeutics Inc. - OVID
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | ADAR1 Capital Management, LLC | 5.1% | 9,559,979 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | ADAR1 Capital Management GP, LLC | 4.9% | 9,122,588 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Daniel Schneeberger | 5.1% | 9,559,979 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 9.9% | 19,549,271 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 9.9% | 19,549,271 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Rajeev Shah | 9.9% | 19,549,271 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 9.9% | 19,549,271 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Eventide Asset Management, LLC | 6.3% | 11,812,241 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Finny Kuruvilla, M.D., Ph. D. | 6.3% | 11,812,241 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Robin C. John | 6.3% | 11,812,241 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BALYASNY ASSET MANAGEMENT L.P. | 4.99% | 9,313,341 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BAM GP LLC | 4.99% | 9,313,341 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Balyasny Asset Management Holdings LP | 4.99% | 9,313,341 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Dames GP LLC | 4.99% | 9,313,341 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Dmitry Balyasny | 4.99% | 9,313,341 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Affinity Asset Advisors, LLC | 7.9% | 15,143,728 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Michael Cho | 7.9% | 15,143,728 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 1.3% | 1,903,943 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 1.3% | 1,903,943 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 1.3% | 1,903,943 | View |
| May 15, 2026 | SCHEDULE 13G | Eventide Asset Management, LLC | 7.3% | 12,773,577 | View |
| May 15, 2026 | SCHEDULE 13G | Finny Kuruvilla, M.D., Ph. D. | 7.3% | 12,773,577 | View |
| May 15, 2026 | SCHEDULE 13G | Robin C. John | 7.3% | 12,773,577 | View |
| May 15, 2026 | SCHEDULE 13G | Sirenia Capital Management LP | 9.9% | 18,031,333 | View |
| May 15, 2026 | SCHEDULE 13G | Alex Silverstein | 9.9% | 18,031,333 | View |
| May 15, 2026 | SCHEDULE 13G | Balyasny Asset Management L.P. | 5.33% | 7,029,223 | View |
| May 15, 2026 | SCHEDULE 13G | BAM GP LLC | 5.33% | 7,029,223 | View |
| May 15, 2026 | SCHEDULE 13G | Balyasny Asset Management Holdings LP | 5.33% | 7,029,223 | View |
| May 15, 2026 | SCHEDULE 13G | Dames GP LLC | 5.33% | 7,029,223 | View |
| May 15, 2026 | SCHEDULE 13G | Dmitry Balyasny | 5.33% | 7,029,223 | View |
| May 14, 2026 | SCHEDULE 13G/A | Jeremy M. Levin | 4.5% | 8,551,502 | View |
| May 14, 2026 | SCHEDULE 13G/A | Affinity Asset Advisors, LLC | 9.1% | 15,635,484 | View |
| May 14, 2026 | SCHEDULE 13G/A | Michael Cho | 9.1% | 15,635,484 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.